HomeNewsBusinessMaldives thanks India for $250 million support amid COVID-19 pandemic
Trending Topics

Maldives thanks India for $250 million support amid COVID-19 pandemic

The financial assistance was announced first during a virtual meeting with External Affairs Minister S Jaishankar and provided through a Treasury Bond sale to the State Bank of India (SBI), Male which has a tenure of 10 years for repayment, the statement said.

September 30, 2020 / 11:22 IST
Story continues below Advertisement
Maldives (Representative image)
Maldives (Representative image)

The Maldives has thanked India for the financial assistance of $250 million -- "the single largest financial assistance from a donor" -- to support the island nation amid the COVID-19 pandemic.

"The pandemic has also highlighted the importance of global cooperation. In the Maldives, without the support of our friends, our bilateral and multilateral partners, we would not be able to continue weathering this storm, Minister of Foreign Affairs of Maldives Abdulla Shahid said in his address to the General Debate of the 75th Session of the United Nations General Assembly on Tuesday.

Story continues below Advertisement

"I thank all our partners who have generously extended financial, material and technical support during this crisis, even when they themselves are going through challenging times. One such example is India. The recent budget support of 250 million US dollars, was the single largest financial assistance from a donor during this pandemic," he said.

The minister said as nations work towards finding a vaccine, Maldives hopes that every person who needs it will have access to it. That we will work together to ensure equitable access.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show